Ibrutinib combined with venetoclax treatment outcome in chronic lymphocytic leukemia: A systematic review

被引:0
|
作者
Sugianto, Jeremy Octavian [1 ]
Purushotama, Nyoman Bagus Satcitta Ananda [1 ]
Ontowirjo, Yudi Ali Putra [1 ]
Sutanto, Mario [1 ]
Kurniawan, Andree [2 ]
机构
[1] Pelita Harapan Univ, Fac Med, Tangerang, Indonesia
[2] Pelita Harapan Univ, Dept Internal Med, Fac Med, Tangerang, Indonesia
关键词
D O I
10.1016/j.annonc.2023.09.345
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P12-9
引用
收藏
页码:S1447 / S1447
页数:1
相关论文
共 50 条
  • [41] Combined Ibrutinib and Venetoclax for First-Line Treatment of Patients with Chronic Lymphocytic Leukemia (CLL): 4-Year Follow-up Data
    Jain, Nitin
    Keating, Michael J.
    Thompson, Philip A.
    Ferrajoli, Alessandra
    Senapati, Jayastu
    Burger, Jan A.
    Borthakur, Gautam
    Takahashi, Koichi
    Estrov, Zeev E.
    Konopleva, Marina
    Sasaki, Koji
    Kadia, Tapan M.
    Pemmaraju, Naveen
    Daver, Naval
    Jabbour, Elias
    DiNardo, Courtney D.
    Alvarado, Yesid
    Yilmaz, Musa
    Bose, Prithviraj
    Ohanian, Maro
    Kanagal-Shamanna, Rashmi
    Patel, Keyur
    Jorgensen, Jeffrey L.
    Wang, Sa A.
    Nassar, Sameh
    Garg, Naveen
    Hwang, Hyunsoo
    Wang, Xuemei
    Cruz, Nichole
    Ayala, Ana
    Plunkett, William
    Kantarjian, Hagop
    Gandhi, Varsha
    Wierda, William G.
    BLOOD, 2022, 140
  • [42] Combined Ibrutinib and Venetoclax for First-Line Treatment of Patients with Chronic Lymphocytic Leukemia (CLL): 5-Year Follow-up Data
    Jain, Nitin
    Keating, Michael J.
    Thompson, Philip A.
    Ferrajoli, Alessandra
    Senapati, Jayastu
    Burger, Jan A.
    Borthakur, Gautam
    Swaminathan, Mahesh
    Takahashi, Koichi
    Estrov, Zeev
    Konopleva, Marina Y.
    Sasaki, Koji
    Kadia, Tapan M.
    Pemmaraju, Naveen
    Daver, Naval
    Jabbour, Elias
    DiNardo, Courtney D.
    Valero, Yesid Alvarado
    Yilmaz, Musa
    Bose, Prithviraj
    Ohanian, Maro
    Kanagal-Shamanna, Rashmi
    Patel, Keyur
    Jorgensen, Jeffrey L.
    Wang, Sa A.
    Nassar, Sameh
    Garg, Naveen
    Hwang, Hyunsoo
    Wang, Xuemei
    Cruz, Nichole
    Ayala, Ana
    Plunkett, William
    Kantarjian, Hagop M.
    Gandhi, Varsha
    Wierda, William G.
    BLOOD, 2023, 142
  • [43] Combinatorial Treatment of Chronic Lymphocytic Leukemia with Ibrutinib and Venetoclax Is Superior to Treatment with Single Agents in the TCL1 Mouse Model
    Slinger, Erik
    Balasubramanian, Sriram
    Leverson, Joel D.
    Eldering, Eric
    Kater, Arnon P.
    BLOOD, 2017, 130
  • [44] Phase 2 Study of Combination Obinutuzumab, Ibrutinib, and Venetoclax in Treatment-Naive and Relapsed/Refractory Chronic Lymphocytic Leukemia
    Rogers, Kerry A.
    Huang, Ying
    Ruppert, Amy S.
    Awan, Farrukh T.
    Hoffman, Corrinne
    Maddocks, Kami J.
    Reid, Mark
    Woyach, Jennifer A.
    Whitlow, Thomas
    Jones, Jeffrey A.
    Byrd, John C.
    BLOOD, 2018, 132
  • [45] Ibrutinib and its use in the treatment o chronic lymphocytic leukemia
    Frustaci, Anna Maria
    Tedeschi, Alessandra
    Deodato, Marina
    Mazzucchelli, Maddalena
    Cairoli, Roberto
    Montillo, Marco
    FUTURE ONCOLOGY, 2018, 14 (08) : 681 - 697
  • [46] IBRUTINIB FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA AND MANTLE CELL LYMPHOMA
    McDermott, J.
    Jimeno, A.
    DRUGS OF TODAY, 2014, 50 (04) : 291 - 300
  • [47] IBRUTINIB TREATMENT IN RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA: A CASE REPORT
    Malkan, U. Yavuz
    Gunes, G.
    Okay, M.
    Aksu, S.
    Sayinalp, N.
    LEUKEMIA RESEARCH, 2016, 49 : S38 - S38
  • [48] Ibrutinib (Imbruvica) for Chronic Lymphocytic Leukemia
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2014, 56 (1440): : 29 - 30
  • [49] Ibrutinib for Chronic Lymphocytic Leukemia REPLY
    Burger, Jan A.
    Styles, Lori
    Kipps, Thomas J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (16) : 1594 - 1595
  • [50] Venetoclax and obinutuzumab in chronic lymphocytic leukemia
    Fischer, Kirsten
    Al-Sawaf, Othman
    Fink, Anna-Maria
    Dixon, Mark
    Bahlo, Jasmin
    Warburton, Simon
    Kipps, Thomas J.
    Weinkove, Robert
    Robinson, Sue
    Seiler, Till
    Opat, Stephen
    Owen, Carolyn
    Lopez, Javier
    Humphrey, Kathryn
    Humerickhouse, Rod
    Tausch, Eugen
    Frenzel, Lukas
    Eichhorst, Barbara
    Wendtner, Clemens-M.
    Stilgenbauer, Stephan
    Langerak, Anton W.
    van Dongen, Jacque J. M.
    Boettcher, Sebastian
    Ritgen, Matthias
    Goede, Valentin
    Mobasher, Mehrdad
    Hallek, Michael
    BLOOD, 2017, 129 (19) : 2702 - 2705